Search Results for 'Dlbcl-X00660069'

Dlbcl-X00660069 published presentations and documents on DocSlides.

Update in Hodgkins & DLBCL
Update in Hodgkins & DLBCL
by debby-jeon
Andy Chen, MD PhD. Center for Hematologic Maligna...
Recent developments in the treatment of DLBCL
Recent developments in the treatment of DLBCL
by payton
Prof. Georg Lenz, MD. Department of Haematology, O...
Treatment Of Later Relapse/ Chemo-Resistant
Treatment Of Later Relapse/ Chemo-Resistant
by ida
Diffuse Large B Cell Lymphoma. Foroud. . shahbazi...
Translating the biology of diffuse large B-cell lymphoma into treatment
Translating the biology of diffuse large B-cell lymphoma into treatment
by callie
Prof. . Alexey V. Danilov, MD, PhD,. 1. Dr. Massi...
1 DLBCL   of the elderly in age older than life expectancy
1 DLBCL of the elderly in age older than life expectancy
by tabitha
the single institute experience in Taiwan . Sheng...
  Precision Medicine For Aggressive Lymphoma
  Precision Medicine For Aggressive Lymphoma
by susan
(PMAL) Consortium and Associated Trials. 2016. CON...
How To Get Lymphoma Patients To CAR-T Therapy In The UK
How To Get Lymphoma Patients To CAR-T Therapy In The UK
by vivian
Dr. Sanne Lugthart. (. Dr. Stephen Robinson). Un...
MYC/BCL2 protein  coexpression
MYC/BCL2 protein coexpression
by Ziggystardust
contributes inferior outcome in DLBCL . ...
Dr. Gilles  Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
Dr. Gilles Salles Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
by isabella2
Dr. Gilles SALLES. Chief . of. . the. . Lymphoma...
Changes in Life Expectation for Diffuse Large
Changes in Life Expectation for Diffuse Large
by roberts
B-Cell . Lymphoma (DLBCL) Patients, . 1983 . – 2...
Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma
by reagan
November 10, 2021. Course Director. John P. Leonar...
 Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
 Updates in Diffuse Large B-Cell Lymphoma
Updates in Diffuse Large B-Cell Lymphoma
by sherrill-nordquist
Program Goals. DLBCL Subtypes . 2008 WHO Classifi...
Burhan Ferhanoglu M.D.
Burhan Ferhanoglu M.D.
by kittie-lecroy
Koç University Medical School Istanbul/Turkey. ...
Jeremy Abramson, MD  Director, Lymphoma Program
Jeremy Abramson, MD Director, Lymphoma Program
by natalie
Jon and Jo Ann Hagler Chair in Lymphoma. Massachus...
CAR T Cells   in non-Hodgkin lymphoma (NHL)
CAR T Cells in non-Hodgkin lymphoma (NHL)
by elena
Jean Koff, MD, MSc. July 20, 2023. disclosures. Re...
HIGH GRADE B
HIGH GRADE B
by luna
- CELL LYMPHOMA DAVID NOLTE, MD (PGY - 2) HUSSAM...
Understanding Lymphoma Series
Understanding Lymphoma Series
by jones
Helpline: 800 500 9976 | helpline@lymphoma.org U...
Understanding Lymphoma Series
Understanding Lymphoma Series
by evans
Helpline: 800 500 9976 | helpline@lymphoma.org U...
NON-HODGKINS LYMPHOMA DR. SANJANA BHAGWAT
NON-HODGKINS LYMPHOMA DR. SANJANA BHAGWAT
by DreamGirl
MODERATOR : DR. GANAPULE . Definition . Lymphomas ...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
CAR-T Therapy in non-Hodgkin lymphomas
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
MYC-associated and Double Hit
MYC-associated and Double Hit
by myesha-ticknor
L. ymphomas. Lisa G Roth, MD. Division of Hematol...